Literature DB >> 12496264

alpha 11beta 1 integrin recognizes the GFOGER sequence in interstitial collagens.

Wan-Ming Zhang1, Jarmo Kapyla, J Santeri Puranen, C Graham Knight, Carl-Fredrik Tiger, Olli T Pentikainen, Mark S Johnson, Richard W Farndale, Jyrki Heino, Donald Gullberg.   

Abstract

The integrins alpha(1)beta(1), alpha(2)beta(1), alpha(10)beta(1), and alpha(11)beta(1) are referred to as a collagen receptor subgroup of the integrin family. Recently, both alpha(1)beta(1) and alpha(2)beta(1) integrins have been shown to recognize triple-helical GFOGER (where single letter amino acid nomenclature is used, O = hydroxyproline) or GFOGER-like motifs found in collagens, despite their distinct binding specificity for various collagen subtypes. In the present study we have investigated the mechanism whereby the latest member in the integrin family, alpha(11)beta(1), recognizes collagens using C2C12 cells transfected with alpha(11) cDNA and the bacterially expressed recombinant alpha(11) I domain. The ligand binding properties of alpha(11)beta(1) were compared with those of alpha(2)beta(1). Mg(2+)-dependent alpha(11)beta(1) binding to type I collagen required micromolar Ca(2+) but was inhibited by 1 mm Ca(2+), whereas alpha(2)beta(1)-mediated binding was refractory to millimolar concentrations of Ca(2+). The bacterially expressed recombinant alpha(11) I domain preference for fibrillar collagens over collagens IV and VI was the same as the alpha(2) I domain. Despite the difference in Ca(2+) sensitivity, alpha(11)beta(1)-expressing cells and the alpha(11) I domain bound to helical GFOGER sequences in a manner similar to alpha(2)beta(1)-expressing cells and the alpha(2) I domain. Modeling of the alpha I domain-collagen peptide complexes could partially explain the observed preference of different I domains for certain GFOGER sequence variations. In summary, our data indicate that the GFOGER sequence in fibrillar collagens is a common recognition motif used by alpha(1)beta(1), alpha(2)beta(1), and also alpha(11)beta(1) integrins. Although alpha(10) and alpha(11) chains show the highest sequence identity, alpha(2) and alpha(11) are more similar with regard to collagen specificity. Future studies will reveal whether alpha(2)beta(1) and alpha(11)beta(1) integrins also show overlapping biological functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496264     DOI: 10.1074/jbc.M210313200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Revealing early steps of alpha2beta1 integrin-mediated adhesion to collagen type I by using single-cell force spectroscopy.

Authors:  Anna Taubenberger; David A Cisneros; Jens Friedrichs; Pierre-Henri Puech; Daniel J Muller; Clemens M Franz
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

Review 2.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

3.  Thermoresponsive Elastin-b-Collagen-Like Peptide Bioconjugate Nanovesicles for Targeted Drug Delivery to Collagen-Containing Matrices.

Authors:  Tianzhi Luo; Michael A David; Lucas C Dunshee; Rebecca A Scott; Morgan A Urello; Christopher Price; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2017-08-01       Impact factor: 6.988

4.  Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates.

Authors:  Shawn M Sweeney; Joseph P Orgel; Andrzej Fertala; Jon D McAuliffe; Kevin R Turner; Gloria A Di Lullo; Steven Chen; Olga Antipova; Shiamalee Perumal; Leena Ala-Kokko; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini; James D San Antonio
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

Review 5.  Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration.

Authors:  Settimio Pacelli; Sayantani Basu; Jonathan Whitlow; Aparna Chakravarti; Francisca Acosta; Arushi Varshney; Saman Modaresi; Cory Berkland; Arghya Paul
Journal:  Adv Drug Deliv Rev       Date:  2017-07-19       Impact factor: 15.470

6.  Enhancing integrin α1 inserted (I) domain affinity to ligand potentiates integrin α1β1-mediated down-regulation of collagen synthesis.

Authors:  Mingjian Shi; Vadim Pedchenko; Briana H Greer; Wade D Van Horn; Samuel A Santoro; Charles R Sanders; Billy G Hudson; Brandt F Eichman; Roy Zent; Ambra Pozzi
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

7.  Dwarfism in mice lacking collagen-binding integrins α2β1 and α11β1 is caused by severely diminished IGF-1 levels.

Authors:  Katrin Blumbach; Anja Niehoff; Bengt F Belgardt; Harald W A Ehlen; Markus Schmitz; Ralf Hallinger; Jan-Niklas Schulz; Jens C Brüning; Thomas Krieg; Markus Schubert; Donald Gullberg; Beate Eckes
Journal:  J Biol Chem       Date:  2011-12-30       Impact factor: 5.157

Review 8.  Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins.

Authors:  Johannes A Eble; Flávia Figueiredo de Rezende
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

9.  Identification of the first prokaryotic collagen sequence motif that mediates binding to human collagen receptors, integrins alpha2beta1 and alpha11beta1.

Authors:  Clayton C Caswell; Malgorzata Barczyk; Douglas R Keene; Ewa Lukomska; Donald E Gullberg; Slawomir Lukomski
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

10.  New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1).

Authors:  Lei Jiang; A Neil Barclay
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.